Atlas Trials

Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes

Clinical trial NCT04485351 · UNKNOWN

Trial details

NCT number
NCT04485351
Sponsor
Central Hospital, Nancy, France
Status
UNKNOWN
Study type
OBSERVATIONAL
Diabetes MellitusCoronavirus InfectionMetabolic DiseaseGlucose Metabolism Disorders
Start date
2020-07-01
Primary completion
2020-08-01
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.